A case of Schistosoma mansoni infection treated during the prepatent period

Nature Clinical Practice Gastroenterology and Hepatology

Volumn 5, Issue 2, 2008, Pages 112-115

  Enk, Martin J ^a   Katz, Naftale ^a,b   Coelho, Paulo Marcos Zech ^a,b  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b Santa Casa Hospital   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

OXAMNIQUINE;

ABSENCE OF SIDE EFFECTS; ACCIDENT; ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DERMATITIS; DISEASE COURSE; FECES ANALYSIS; FEMALE; HUMAN; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; SINGLE DRUG DOSE; WATER CONTAMINATION;

ADMINISTRATION, ORAL; ADULT; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; FECES; FEMALE; FOLLOW-UP STUDIES; HUMANS; OXAMNIQUINE; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; SCHISTOSOMICIDES;

EID: 39049172968     PISSN: 17434378     EISSN: 17434386     Source Type: Journal    
DOI: 10.1038/ncpgasthep1037     Document Type: Article

References (16)

1. Katz N et al. (1972) A simple device for quantitative stool thick-smear technique Schistosomiasis mansoni. Rev Inst Med Trop Sao Paulo 14: 397-400
2. Blagg W et al. (1955) A new concentration technic for the demonstration of protozoa and helminth eggs in faces. Am J Trop Med Hyg 4: 23-28
3. Chitsulo L et al. (2000) The global status of schistosomiasis and its control. Acta Trop 23:41-51
4. Meltzer E et al. (2006) Schistosomiasis among travelers: New aspects of an old disease. Emerg Infect Dis 12: 1696-1700
5. Corachan M (2002) Schistosomiasis and international travel. Clin Infect Dis 35: 446-450
6. Gryseels B et al. (2006) Human schistosomiasis. Lancet 368: 1106-1118
7. Bottieau E et al. (2006) Imported Katayama fever: Clinical and biological features at presentation and during treatment. J Infect 52: 339-345
8. Foster R et al. (1971) The control of immature Schistasoma mansoni in mice by UK 3883, a novel 2-aminomethyltetrahydroquinoline derivative. Ann Trop Med Parasitol 65: 221-232
9. Foster R (1987) A review of clinical experience with oxamniquine. Trans R Soc Trop Med Hyg 81: 55-59
10. Utzinger J et al. (2003) Combination chemotherapy of schistosomiasis in laboratory studies and clinical trials. Antimicrob Agents Chemother 47: 1486-1495
11. Sabah AA et al. (1986) Schistosoma mansonichemotherapy of infections of different ages. Exp Parasitol 61: 294-303
12. Coelho PMZ et al. (1998) Activity of oxamniquine at skin, pulmonary and sexual maturation phases 08 a Schistosoma mansoni strain (R1) previously reported resistant at the adult phase. Mem Inst Oswaldo Cruz 93 (Suppl 1): S267-S268
13. Coelho PMZ et al. (1993) Schistosoma mansoni: Evaluation of the activity of oxamniquine on schistosomula at 24 hours after infection. Rev Inst Med Trop Sao Paulo 35: 557-561
14. Katz N et al. (1973) Further clinical trails with oxamniquine, a new antischistosomal agent. Rev Inst Med Trop Sao Paulo 15 (Suppl 1): S35-S40
15. Shaohong L (2006) Evaluation of the anthelmintic effects of artesunate against experimental Schistosoma mansoni infection in mice using different treatment protocols. Parasitol Int 55: 63-68
16. Xiou S et al. (2002) Recent investigations of artemether, a novel agent for the prevention of Schistosomiasis japonica, mansoni and haematobia. Acta Trop 82: 175-181